Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
37 results
- 3상모집 중· Alzheimer's Disease인지기능이 정상인 증상성 알츠하이머병 진행 위험군에서의 트로틴네맙 연구
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
리드: 로슈
- 3상모집 중· Non-small Cell Lung Cancer절제된 KRAS G12C 양성 2-3기 비소세포폐암(NSCLC) 환자에서 디바라십과 연구자 선택 면역요법 또는 관찰의 유효성 및 안전성 비교 연구
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
- 3상모집 중· Early Breast CancerER+/HER2- 조기 유방암 환자의 기레데스트란트 복약순응도 및 환자 보고 결과 평가: 아로마타제 억제제 불내약성 (novERA 유방암)
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
리드: 로슈
- 3상모집 중· Moderately to Severely Active Crohns Disease중등도~중증 활동성 크론병 소아의 Afimkibart 약동학·유효성·안전성 연구
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 3상모집 중· Obesity비만 또는 과체중 환자(제2형 당뇨병 유무 불문)에서 에니세파타이드의 효과 평가
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
리드: 로슈
- 3상모집 중· Multiple Myeloma이전에 치료받은 다발성 골수종 환자에서 세보스타맙과 포말리도마이드 및 덱사메타손의 병용 대 표준 치료 비교 연구
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
리드: 로슈
- 3상모집 중· Hemophilia A혈우병 A 환자를 대상으로 NXT007과 제8인자 예방 치료의 효과를 평가하는 임상 연구
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
리드: 로슈
- 3상모집 중· Neuromyelitis Optica Spectrum Disorder아쿠아포린-4 항체 양성 신경척수염 시신경염 스펙트럼 장애(NMOSD) 소아 환자에서 사트랄리주맙의 약동학, 유효성, 안전성, 내약성 및 약력학 평가 연구
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
리드: 로슈
- 3상모집 중· Hemophilia A혈우병 A에서 NXT007과 에미시주맙 예방 요법 비교 평가
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
리드: 로슈
- 3상모집 중· Moderately to Severely Active Ulcerative Colitis중등도 이상의 활동성 궤양성 대장염 소아에서 아핌키바트(RO7790121)의 약동학, 안전성 및 유효성 평가
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
리드: 로슈
- 3상모집 중· Neovascular Age-related Macular DegenerationA Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
리드: 로슈
- 3상모집 중· Alzheimers DiseaseA Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
리드: 로슈
- 3상모집 중· Non-Small Cell Lung CancerA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
리드: 로슈
- 3상모집 중· High Risk Cardiovascular DiseaseZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
협력: 로슈
- 3상모집 중· Alzheimers DiseaseA Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
리드: 로슈
- 3상모집 중· Proliferative Diabetic Retinopathy (PDR)Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
협력: 로슈
- 3상모집 중· Alzheimers DiseaseScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
리드: 로슈
- 3상모집 중· Von Willebrand Disease, Type 3A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
리드: 로슈
- 3상모집 중· Moderately to Severely Active Crohns DiseaseA Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 3상모집 중· Moderately to Severely Active Crohns DiseaseA Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 3상모집 중· Moderately to Severely Active Ulcerative ColitisA Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 로슈
- 3상모집 중· Acute Myeloid LeukemiaVenetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
협력: 애브비, 로슈
- 3상모집 중· Ovarian Neoplasm EpithelialMAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
협력: 노바티스, 로슈
- 3상모집 중· Neovascular Age-Related Macular DegenerationExtension Study for the Port Delivery System With Ranibizumab (Portal)
리드: 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.